Clinical Trials
Cmed to Demonstrate the Capture, Visualization and RTA of Clinical Data using encapsia® at Mobile in Clinical Trials and DPharm 2017
Cmed has announced it will present its encapsia® clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017....
Clinical Trials
Initiation of Cytisine Clinical Development Program Announced By Achieve
Achieve Life Sciences, Inc. a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced initiation of the...
Clinical Trials
BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial
BioSight, Ltd, a pharmaceutical development company, focused on the development of targeted oncology therapeutics with reduced toxicity, announced completion of last patient treatment in its...
Clinical Trials
Randomization In Phase 2/3 Trial In Spinocerebellar Ataxia Completed By Biohaven
Biohaven Pharmaceutical Holding Company Ltd. announced today that it has commenced dosing of all 141 randomized patients with spinocerebellar ataxia (SCA) in...
Clinical Trials
Kite Doses First Patient in the Phase 2 Trial of Axicabtagene Ciloleucel in Indolent B-Cell Non-Hodgkin Lymphoma
Kite Pharma, Inc , a leading cell therapy company announced that patients with relapsed/refractory indolent B-cell non-Hodgkin lymphoma (iNHL) are now being treated in its...
Clinical Trials
Phase III Study Of Viaskin Peanut – Allergic Of Patients One To Three Years Of Age Initiated By DBV Technologies
DBV Technologies announced that the first patient has been enrolled in EPITOPE ( EPIT in TO ddlers with PE anut Allergy), a global, Phase...
Clinical Trials
Positive Results From The Phase 2 AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis Announced By Intercept
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.